Evidence map›Paper›PMID 34336446›Full record

ArticleCureus2021

Acute Pancreatitis-Induced Euglycemic Diabetic Ketoacidosis.

Arslan Chaudhry, Christopher Biggiani, Muhammad Afzal, Sohail Chaudhry, Yazan Vwich

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Arslan ChaudhryInternal Medicine, Saint Joseph's Regional Medical Center, Paterson, USA.
Christopher BiggianiInternal Medicine, Saint Joseph's Regional Medical Center, Paterson, USA.
Muhammad AfzalInternal Medicine, Saint Joseph's Regional Medical Center, Paterson, USA.
Sohail ChaudhryInternal Medicine, Saint Joseph's Regional Medical Center, Paterson, USA.
Yazan VwichEndocrinology, Diabetes, and Metabolism, Saint Joseph's Regional Medical Center, Paterson, USA.
St. Joseph’s University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a class of medications utilized for the treatment of diabetes mellitus by mechanisms promoting incretin release and insulin production. Although poorly understood, cases of acute pancreatitis have been observed in patients taking GLP-1 RAs. Sodium-glucose co-transporter-2 inhibitors (SGLT-2is) are another class of diabetic medications inhibiting renal glucose reabsorption which have been associated with rare cases of euglycemic ketoacidosis. Acute pancreatitis itself has been an observable cause of diabetic ketoacidosis, although typically in a hyperglycemia state. In this case report, we present a patient on SGLT-2is and GLP-1 RAs who developed acute pancreatitis, which may have precipitated euglycemic diabetic ketoacidosis (eu-DKA).

Indexed as

acute pancreatitiseuglycemic diabetic ketoacidosisglp-1 agonistsglt-2 inhibitortype-2 diabetes mellitus

Identifiers

PMID34336446
PMCPMC8312994
OpenAlexW3176629982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.